This clustering, especially regarding the DR5 receptor, is not exclusively cancer cell selective and is generally considered undesired due to unintentional side effects exerted on normal host cells also capable of expressing DR4 and/or DR5 [25]. The gene discussed is TNFRSF10B; the disease is cancer.